http://www..ias2009.org

5th International AIDS Society Conference on HIV Pathogenesis and Treatment


Cape Town - July 19 - 22, 2009


DISSECTING T CELL RESPONSIVENESS TO γC-CYTOKINE IN HIV INFECTED SUBJECTS

IAS Conf HIV Pathog Treat 2009 Jul 19-22;5th: Abstract No. MOAA105

C. Riou 1, N. Malatsi1, G. De Bruyn2, R.-P. Sekaly3, C.M. Gray1
1NICD, HIV/AIDS unit, Johannesburg, South Africa, 2Chris Hani Baragwanath Hospital, PHRU, Johannesburg, South Africa, 3University of Montreal, Immunology, Montreal, Canada


BACKGROUND: γC-cytokines play a central role in controlling T cell proliferation, differentiation and survival. It is well established that HIV-specific cells are defective in their ability to produce cytokines such as IL2. However, less is known on the ability of T cells to respond to cytokines. To define if abnormal responses to immune-activation signals could lead to T cell dysfunction and inability of T cells to control HIV replication, we analyzed the phosphorylation profiles of different Tcell subsets and HIV-specific cells in response to exogenous γC-cytokines.

METHODS: In a cohort of 11 HIV infected and 11 un-infected individuals, we assessed the profile of Stat-5 phosphorylation in total and HIV-specific cells in response to a brief exposure (15 min) to sub-optimal concentrations of IL-2 (300U/ml), IL- 7 (0.2ng/ml) and IL-15 (0.5ng/ml) using 7-color-flow cytometry.

RESULTS: In both HIV-positive and HIV-negative individuals, memory T cell responsiveness to γC-cytokines significantly decreased with cell differentiation in the CD4 and CD8 compartments, where Central Memory cells (CD45RACD27+ CCR7+) display the highest responsiveness to IL-2, IL7 and IL-15 and Effector cells (CD45RA+CD27-CCR7-) the lowest. No significant differences in Stat-5 phosphorylation were observed between HIV-positive and HIV- individuals in any subsets of total CD4 or CD8 T-cells. Importantly, HIV-specific cells were characterized by a 2-fold decrease in Stat- 5 phosphorylation in response to IL-2 triggering as compared to CMV-specific cells, despite a functional IL-7 pathway.

CONCLUSIONS: Our results indicate that T cell differentiation affects γC-cytokine responsiveness where terminally differentiated cells lose their ability to respond to cytokines. In HIV-specific cells, impaired responsiveness to IL-2 could play a role in generating functionally inefficient antigen-specific cells. Thus, differentiation status and antigen specificity both appear to have a role in determining responsiveness to immune activation signals.

2009-07-22
MOAA105
Oral Abstract Session MOAA1 - Control of HIV by Cellular Immunity


Copyright © 2009 - International AIDS Society (IAS). All information and content relating to the abstracts from the 5th International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.